Use of biological therapies in adult patients diagnosed with juvenile idiopathic arthritis: results from BIOBADASER, the Spanish registry of adverse events with biologic therapies
14/08/2023
J.J. Bethencourt Baute1 , C. Sanchez-Piedra2 , F. Sanchez-Alonso2 , D. RuizMontesinos3 , J. Manero4 , C. Rodriguez-Lozano5 , E. Perez-Pampin6 , A. Ortiz7 , S. Manrique8 , M.V. Hernandez9 , C. Campos10, A. Sellas11, A. Sifuentes12, J. García-González13, J.J. Gomez-Reino14, F. Díaz-Gonzalez15, S. BustabadReyes16, on behalf of BIOBADASER STUDY GROUP
EULAR 2018
DOI: 10.1136/annrheumdis-2018-eular.5942
https://ard.bmj.com/content/77/Suppl_2/491.2